Taconic Insights

Biopharmaceutical Trends and R&D

Taconic Biosciences has remained one of the world's leading providers of research models and services for over 60 years through our commitment to anticipating clients’ needs and industry trends. One of the key trends of the past ten years involves our clients’ need to strategically outsource functional areas of their R&D programs. When companies, academic institutions, government agencies and others outsource certain R&D functions they begin to rely on their collaborators, such as Taconic, to keep them apprised of emerging science and technologies in our specific areas of expertise.
In this spirit of collaboration, we present "Taconic Insights", a new section of our website dedicated to educating the industry on key scientific and technological trends impacting biopharmaceutical R&D. Here you will find the latest insights Taconic can provide in the form of articles, white papers, videos, webinars, presentations, and other media.

Business Continuity Planning in Life Sciences

"What do you mean you don't have the animals I need available? You've always had them before. Don't you know this will delay lifesaving research and possibly cost me my grant?" Supply chain disruptions for critical business components isn't an uncommonly rare event. In fact, disruptions, disasters, and accidents occur often. Incorporating business continuity planning into your colony management strategy is the only way to keep your...

Read More

SFB and Immune Response in Animal Models

Segmented filamentous bacteria (SFB, provisional classification Candidatus Savagella) are commensal microorganisms endemic to all vertebrate classes, including mice and humans. SFB are notable for their ability to modulate adaptive host immune responses, including induction of regulatory Th17 T cells, Peyer's patch maturation, and gut IgA production1-3. A recent study from the laboratory of Joyce Wu at the University of Arizona has revealed a novel innate immune function...

Read More

PD-1 Blockade Ineffective in AD Mouse Models

More than 45 million people worldwide suffer from Alzheimer's disease (AD) or dementia. The costs are staggering, and no cure exists. Development of new therapies has been challenging, with many promising new drugs failing in late stage clinical trials. Inducing Immune Response in AD Mouse Models Interest in new therapeutic pathways was piqued in 2016, when Baruch et al. reported that PD-1 checkpoint inhibition induced an immune...

Read More

Webinar Q&A — Using Diet-Induced Obese Mice to Study Metabolic Disease

In a recent webinar, Dr. Michael Briggs and Mrs. Nikole Siegmund of Woodland Biosciences discussed use of diet-induced obese (DIO) mice for metabolic disease research. The speakers explained how DIO mice can be used in a range of study types, including: Obesity reduction Obesity-related inflammation Diabetes readouts such as glucose Obesity-related cancer Examples of typical studies using real (anonymized) data were shown. Obesity-driven metabolic diseases, including non-alcoholic...

Read More

New PBMC-humanized Mice Support Efficient NK-cell Engraftment

Favored for their relative speed, versatility, and translational relevance, humanized mice engrafted with human peripheral blood mononuclear cells (PBMCs) are the go-to preclinical models for evaluating T-cell-dependent immunotherapies. However, lacking important human cytokine signals, huPBMC-NOG and other PBMC models fail to support engraftment of important human immune cell subtypes, such as natural killer (NK) cells. This limits their utility for many studies. Recent work from Taconic Biosciences...

Read More

Webinar Q&A — Next Generation Humanized Mice in IO

The preclinical research community responded enthusiastically to Dr. Paul Volden's recent webinar, Next Generation Humanized Mice in Immuno-Oncology, the second webinar in a two-part series on humanized mice for preclinical immuno-oncology (IO). Several questions had to be cut from the presentation for time and are presented here, in full. Preclinical Immuno-Oncology Q&A Dr. Paul Volden (PV): The number of cells obtained from individual hematopoietic stem cell (HSC)...

Read More

Introduction to Translational Microbiome Research Infographic

Download Taconic Biosciences' new infographic, Translational Microbiome at a Glance, for valuable insights into the translational aspects of microbiome research. Intended for those just beginning their work, Translational Microbiome at a Glance covers critical introductory subjects such as: The six factors that shape the mouse microbiome — and study endpoints Disease associations that can impact experimental performance Investment and intellectual property status Applications of germ-free mice in...

Read More

Application of CRISPR/Cas to the Generation of Genetically Engineered Mice White Paper

UPDATE: This White Paper has been updated in 2018 to reflect the latest technological advances and usage recommendations of CRISPR/Cas in the generation of research models. CRISPR/Cas gene editing has emerged as a versatile technology for inducing precise genetic alterations in a number of different species, including mice and rats. Given the importance of genetically engineered mice in modeling human disease, the power of CRISPR has the...

Read More

The Long-Term Impacts of Traumatic Brain Injury

National Vital Statistics System Mortality Data — United States, 2001-2010 (Deaths) Traumatic brain injury (TBI) is a growing problem. An estimated 10 million people are affected annually worldwide by TBI, and the burden of mortality and morbidity that imposes on society makes TBI a pressing public health and medical problem1. The populations most at risk are children, teens, and the elderly and TBI contributes to numerous hospital...

Read More

Research on Common Ocular Abnormalities in C57BL/6N Mice

In May 2018 researchers at the University of California-Davis and Université de Strasbourg published a paper titled, A Population Study of Common Ocular Abnormalities in C57BL/6N rd8 Mice in the journal, Investigative Ophthalmology and Visual Science. C57BL/6N mice, which carry the rd8 mutation, are the most commonly used model for generation of knockout models. This study looked at a large cohort of C57BL/6N mice which were sourced...

Read More